A citation-based method for searching scientific literature

So Ra Kim, Sang-Guk Lee, Soo Hyun Kim, Jin Hee Kim, Eunhye Choi, Wonhee Cho, John Hoon Rim, Inhwa Hwang, Chan Joo Lee, Minyoung Lee, Chang-Myung Oh, Justin Y Jeon, Heon Yung Gee, Jeong-Ho Kim, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Myung-Shik Lee, Je-Wook Yu, Jin Won Cho, Jung-Sun Kim, Yong-Ho Lee. Nat Commun 2020
Times Cited: 144



H J Lambers Heerspink, D de Zeeuw, L Wie, B Leslie, J List. Diabetes Obes Metab 2013
Times Cited: 503




List of shared articles



Times cited

SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms.
Maja Nikolic, Vladimir Zivkovic, Jovana Joksimovic Jovic, Jasmina Sretenovic, Goran Davidovic, Stefan Simovic, Danijela Djokovic, Nemanja Muric, Sergey Bolevich, Vladimir Jakovljevic. Heart Fail Rev 2022
15

Ketone therapy for heart failure: current evidence for clinical use.
Shingo Takahara, Shubham Soni, Zaid H Maayah, Mourad Ferdaoussi, Jason R B Dyck. Cardiovasc Res 2022
9


Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis.
Milijana Janjusevic, Alessandra Lucia Fluca, Giulia Gagno, Alessandro Pierri, Laura Padoan, Annamaria Sorrentino, Antonio Paolo Beltrami, Gianfranco Sinagra, Aneta Aleksova. Int J Mol Sci 2022
2

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors.
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, Luca Rinaldi, Anna Di Martino, Gaetana Albanese, Jessica Di Salvo, Raffaella Epifani, Raffaele Marfella, Giovanni Docimo,[...]. Int J Mol Sci 2022
8


Dapagliflozin for the treatment of chronic kidney disease.
Yu Kurata, Masaomi Nangaku. Expert Rev Endocrinol Metab 2022
0

Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role?
Asmaa Elrakaybi, Katharina Laubner, Qian Zhou, Martin J Hug, Jochen Seufert. Mol Metab 2022
1

SGLT2 Inhibitors: New Hope for the Treatment of Acute Myocardial Infarction?
Yu-Jie Wu, Si-Bo Wang, Lian-Sheng Wang. Am J Cardiovasc Drugs 2022
0

Managing Covid-19 in patients with heart failure: current status and future prospects.
Hawani Sasmaya Prameswari, Iwan Cahyo Santosa Putra, Wilson Matthew Raffaello, Michael Nathaniel, Adrian Sebastian Suhendro, Achmad Fitrah Khalid, Raymond Pranata. Expert Rev Cardiovasc Ther 2022
0

Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.
Mikhail Kosiborod, Otavio Berwanger, Gary G Koch, Felipe Martinez, Omar Mukhtar, Subodh Verma, Vijay Chopra, Ali Javaheri, Philip Ambery, Samvel B Gasparyan,[...]. Diabetes Obes Metab 2021
24

Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics.
Zhenghong Liu, Xiaoxuan Ma, Iqra Ilyas, Xueying Zheng, Sihui Luo, Peter J Little, Danielle Kamato, Amirhossein Sahebkar, Weiming Wu, Jianping Weng,[...]. Theranostics 2021
27